weight loss drug news today glp-1 october 2025 drugs leave users low on key nutrients, study finds How do weight-loss drugs work?

GLP-1 therapy is generally recommended for individuals diagnosed with type 2 diabetes who require additional glycemic control, patients with a body mass index (BMI) greater than 27, especially those with weight-related comorbidities, and those not achieving target blood glucose levels with metformin or other oral hypoglycemic agents

You can meet your specific health goals when you use GLP-1 Weight Loss Medications

Clinical trial data from the STEP and SURMOUNT programs demonstrate that maximum weight loss typically occurs between 60-72 weeks of treatment, with most patients losing 1-2 pounds per week during the active weight loss phase

Myocardial Infarction Subtypes in Patients With Type 2 Diabetes Mellitus and the Effect of Liraglutide Therapy (from the LEADER Trial)